Clonal expansion and epigenetic reprogramming following deletion or amplification of mutantIDH1
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clonal expansion and epigenetic reprogramming following deletion or amplification of mutantIDH1
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 114, Issue 40, Pages 10743-10748
Publisher
Proceedings of the National Academy of Sciences
Online
2017-09-16
DOI
10.1073/pnas.1708914114
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity
- (2017) Parker L. Sulkowski et al. Science Translational Medicine
- Metabolic Profiling of IDH Mutation and Malignant Progression in Infiltrating Glioma
- (2017) Llewellyn E. Jalbert et al. Scientific Reports
- IDH mutations in cancer and progress toward development of targeted therapeutics
- (2016) L. Dang et al. ANNALS OF ONCOLOGY
- Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2
- (2016) Satoshi Inoue et al. CANCER CELL
- Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
- (2016) Michele Ceccarelli et al. CELL
- Isocitrate dehydrogenase mutations in myeloid malignancies
- (2016) B C Medeiros et al. LEUKEMIA
- Rapid Conversion of Mutant IDH1 from Driver to Passenger in a Model of Human Gliomagenesis
- (2016) T.-C. A. Johannessen et al. MOLECULAR CANCER RESEARCH
- Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment
- (2015) Hinke F. van Thuijl et al. ACTA NEUROPATHOLOGICA
- Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosome
- (2015) F. Favero et al. ANNALS OF ONCOLOGY
- Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion
- (2015) Kensuke Tateishi et al. CANCER CELL
- DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors
- (2015) Tali Mazor et al. CANCER CELL
- Insulator dysfunction and oncogene activation in IDH mutant gliomas
- (2015) William A. Flavahan et al. NATURE
- New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
- (2015) Ujunwa C Okoye-Okafor et al. Nature Chemical Biology
- Mutational landscape and clonal architecture in grade II and III gliomas
- (2015) Hiromichi Suzuki et al. NATURE GENETICS
- Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
- (2015) Jeanette E. Eckel-Passow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Targetable Signaling Pathway Mutations Are Associated with Malignant Phenotype in IDH-Mutant Gliomas
- (2014) H. Wakimoto et al. CLINICAL CANCER RESEARCH
- D-2-Hydroxyglutarate producing neo-enzymatic activity inversely correlates with frequency of the type of isocitrate dehydrogenase 1 mutations found in glioma
- (2014) Stefan Pusch et al. Acta Neuropathologica Communications
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
- (2013) J.-A. Losman et al. GENES & DEVELOPMENT
- Spontaneous loss of heterozygosity leading to homozygous R132H in a patient-derived IDH1 mutant cell line
- (2013) H. A. Luchman et al. NEURO-ONCOLOGY
- Lactate dehydrogenase A silencing in IDH mutant gliomas
- (2013) Charles Chesnelong et al. NEURO-ONCOLOGY
- (R)-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible
- (2013) J.-A. Losman et al. SCIENCE
- Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma
- (2013) B. E. Johnson et al. SCIENCE
- An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
- (2013) D. Rohle et al. SCIENCE
- Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation
- (2013) F. Wang et al. SCIENCE
- Disruption of Wild-Type IDH1 Suppresses D-2-Hydroxyglutarate Production in IDH1-Mutated Gliomas
- (2012) G. Jin et al. CANCER RESEARCH
- The Potential for Isocitrate Dehydrogenase Mutations to Produce 2-Hydroxyglutarate Depends on Allele Specificity and Subcellular Compartmentalization
- (2012) Patrick S. Ward et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- IDH mutation impairs histone demethylation and results in a block to cell differentiation
- (2012) Chao Lu et al. NATURE
- IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics
- (2012) Masato Sasaki et al. NATURE
- Magnetic Resonance of 2-Hydroxyglutarate in IDH1-Mutated Low-Grade Gliomas
- (2012) A. Elkhaled et al. Science Translational Medicine
- IDH1 R132H decreases proliferation of glioma cell lines in vitro and in vivo
- (2011) Linda B. C. Bralten et al. ANNALS OF NEUROLOGY
- A Tale of Two Subunits: How the Neomorphic R132H IDH1 Mutation Enhances Production of αHG
- (2011) Beth Pietrak et al. BIOCHEMISTRY
- Glioma cells showing IDH1 mutation cannot be propagated in standard cell culture conditions
- (2011) S Piaskowski et al. BRITISH JOURNAL OF CANCER
- IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma
- (2011) Qi SongTao et al. CANCER SCIENCE
- An in vivo patient-derived model of endogenous IDH1-mutant glioma
- (2011) H. A. Luchman et al. NEURO-ONCOLOGY
- 2-Hydroxyglutarate Production, but Not Dominant Negative Function, Is Conferred by Glioma-Derived NADP+-Dependent Isocitrate Dehydrogenase Mutations
- (2011) Genglin Jin et al. PLoS One
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
- (2010) Houtan Noushmehr et al. CANCER CELL
- Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
- (2010) Maria E. Figueroa et al. CANCER CELL
- Oligodendroglioma cell lines containing t(1;19)(q10;p10)
- (2010) J. J. P. Kelly et al. NEURO-ONCOLOGY
- Scientific correspondence
- (2010) S. Pusch et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- IDH1 Mutations Are Early Events in the Development of Astrocytomas and Oligodendrogliomas
- (2009) Takuya Watanabe et al. AMERICAN JOURNAL OF PATHOLOGY
- Differentiation therapy of leukemia: 3 decades of development
- (2009) D. Nowak et al. BLOOD
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- (2009) Lenny Dang et al. NATURE
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proliferation of Human Glioblastoma Stem Cells Occurs Independently of Exogenous Mitogens
- (2009) John J. P. Kelly et al. STEM CELLS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started